Sign in

CIK 0001513525 · Non-accelerated filer<br>Smaller reporting company

Azora Therapeutics, Inc. (DE)

Sign in to watch
Ticker
AZR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
800667150
Phone
434-422-9800
Business address
16501 VENTURA BLVD, SUITE 400, ENCINO, CA, 91436
Former names
ADIAL PHARMACEUTICALS, INC., Adial Pharmaceuticals, L.L.C., ADial Pharmaceuticals, L.L.C.
  1. 8-K Event Regulation FD disclosure · Other events
  2. DEF 14A Proxy Proxy Statement
  3. D Other Notice of Sales of Unregistered Securities
  4. 8-K Event Delisting notice
  5. 8-K Event Other events
  6. PRE 14A Proxy Proxy Statement (Preliminary)
  7. 424B5 Offering Prospectus
  8. 8-K Event Material agreement · Unregistered share sale · Other events
  9. 8-K Event Regulation FD disclosure · Other events
  10. 8-K Event Material agreement · Regulation FD disclosure
  11. 4 Returned to the company Director returned 166,667 shares (to the company)
  12. 8-K Event Results of operations
  13. 10-Q Report Quarterly Report
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 8-K Event Executive or director change · Shareholder vote results
  16. 8-K Event Regulation FD disclosure · Other events
  17. 4 Grant or award Chief Executive Officer acquired 100,000 shares (grant or award)
  18. 8-K Event Auditor change
  19. 8-K Event Executive or director change
  20. 8-K Event Regulation FD disclosure · Other events

Page 13 of 30 · 581 filings